[go: up one dir, main page]

CN116144690A - A shuttle vector pDXA between Escherichia coli and lactic acid bacteria and its construction method and application - Google Patents

A shuttle vector pDXA between Escherichia coli and lactic acid bacteria and its construction method and application Download PDF

Info

Publication number
CN116144690A
CN116144690A CN202211010845.XA CN202211010845A CN116144690A CN 116144690 A CN116144690 A CN 116144690A CN 202211010845 A CN202211010845 A CN 202211010845A CN 116144690 A CN116144690 A CN 116144690A
Authority
CN
China
Prior art keywords
pdxa
escherichia coli
plasmid
lactic acid
lactobacillus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202211010845.XA
Other languages
Chinese (zh)
Inventor
顾斌涛
袁林
郭建军
曾静
聂俊辉
王通
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institute Of Microbiology Jiangxi Academy Of Sciences Jiangxi Institute Of Watershed Ecology
Original Assignee
Institute Of Microbiology Jiangxi Academy Of Sciences Jiangxi Institute Of Watershed Ecology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institute Of Microbiology Jiangxi Academy Of Sciences Jiangxi Institute Of Watershed Ecology filed Critical Institute Of Microbiology Jiangxi Academy Of Sciences Jiangxi Institute Of Watershed Ecology
Priority to CN202211010845.XA priority Critical patent/CN116144690A/en
Publication of CN116144690A publication Critical patent/CN116144690A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/746Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for lactic acid bacteria (Streptococcus; Lactococcus; Lactobacillus; Pediococcus; Enterococcus; Leuconostoc; Propionibacterium; Bifidobacterium; Sporolactobacillus)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/65Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression using markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention discloses a shuttle vector pDXA of escherichia coli and lactobacillus, a construction method and application thereof, and belongs to the field of molecular biology. The shuttle vector pDXA is constructed and obtained by synthesizing ampicillin resistance gene and promoter and pMB1 replicon sequence through genes and connecting the genes to lactobacillus acidophilus plasmid pDX. The shuttle vector pDXA of the present invention can replicate and express foreign genes in E.coli and various lactic acid bacteria. The plasmid vector is used for completing the cloning of target genes and the construction of vectors in an escherichia coli host, thereby facilitating the development of functional gene expression research and lactobacillus genetic modification in lactobacillus.

Description

一种大肠杆菌与乳酸菌的穿梭载体pDXA及构建方法与应用A shuttle vector pDXA between Escherichia coli and lactic acid bacteria and its construction method and application

技术领域technical field

本发明属于分子生物学领域,具体涉及一种大肠杆菌与乳酸菌的穿梭载体pDXA及构建方法与应用。The invention belongs to the field of molecular biology, and in particular relates to a shuttle vector pDXA between Escherichia coli and lactic acid bacteria, its construction method and application.

背景技术Background technique

乳酸菌是一类能够利用碳水化合物发酵产生乳酸的各类细菌总称,在自然界中广泛存在,分布于土壤、湖泊、动物、植物和发酵食品中。乳酸菌是一种益生菌,人类消化系统中的乳酸菌可以调节菌群的微生态平衡,促进乳糖等营养物质的消化吸收,抑制腐败菌的生长,消除腐败菌产生的毒素,改善胃肠道功能,增强机体免疫力等。此外,乳酸菌在农业、食品和医药等领域具有很高的应用价值。嗜酸乳杆菌(Lactobacillus acidophilus)属于乳杆菌属,广泛应用于各类功能性食品中,是乳酸菌中极其重视研究与开发的食品级益生菌。Lactic acid bacteria is a general term for various bacteria that can use carbohydrate fermentation to produce lactic acid. It exists widely in nature and is distributed in soil, lakes, animals, plants and fermented foods. Lactic acid bacteria are a kind of probiotics. Lactic acid bacteria in the human digestive system can adjust the micro-ecological balance of the flora, promote the digestion and absorption of nutrients such as lactose, inhibit the growth of spoilage bacteria, eliminate the toxins produced by spoilage bacteria, and improve the function of the gastrointestinal tract. Enhance the body's immunity, etc. In addition, lactic acid bacteria have high application value in fields such as agriculture, food and medicine. Lactobacillus acidophilus belongs to the genus Lactobacillus and is widely used in various functional foods. It is a food-grade probiotic that attaches great importance to research and development among lactic acid bacteria.

质粒是细菌、酵母菌和放线菌等微生物中染色体之外,存在于细胞质中的具有自主复制能力的闭合环状DNA分子。质粒的编码特征大多对菌种有利,可以提高菌种的生存优势。乳酸菌可携带不同大小的多个质粒,其中大多数质粒为隐蔽性质粒,另外一些质粒则具有某些特殊功能,质粒常被构建菌种间穿梭的载体。大肠杆菌中的基因克隆比较成熟便利,乳酸菌的转化比大肠杆菌转化更繁琐,转化效率相对较低,构建一种能在大肠杆菌和乳酸菌之间穿梭的载体,能提高在乳酸菌中开展基因工程操作的效率。Plasmids are closed circular DNA molecules with autonomous replication ability that exist in the cytoplasm outside the chromosomes of microorganisms such as bacteria, yeasts, and actinomycetes. Most of the coding features of the plasmid are beneficial to the strain and can improve the survival advantage of the strain. Lactic acid bacteria can carry multiple plasmids of different sizes, most of which are cryptic plasmids, and some other plasmids have certain special functions. Plasmids are often used to construct vectors for the shuttle between strains. Gene cloning in Escherichia coli is more mature and convenient, the transformation of lactic acid bacteria is more complicated than that of Escherichia coli, and the transformation efficiency is relatively low, constructing a vector that can shuttle between Escherichia coli and lactic acid bacteria can improve the genetic engineering operation in lactic acid bacteria s efficiency.

发明内容Contents of the invention

本发明的目的在于提供一种在大肠杆菌和乳酸菌之间穿梭的载体,以解决乳酸菌中异源基因导入较难的问题,本发明的另一个目的在于提供用于大肠杆菌表达的乳酸菌启动子。The object of the present invention is to provide a carrier that shuttles between Escherichia coli and lactic acid bacteria, so as to solve the difficult problem of heterologous gene introduction in lactic acid bacteria. Another object of the present invention is to provide a lactic acid bacteria promoter for E. coli expression.

本发明提供了在大肠杆菌和乳酸菌之间穿梭的载体,该穿梭载体由将氨苄青霉素抗性基因及启动子和pMB1复制子序列连接到嗜酸乳杆菌质粒pDX中获得,其穿梭载体pDXA碱基序列如SEQ ID NO:1所示;所述质粒pDX序列如SEQ ID NO:2所示。The present invention provides a vector for shuttling between Escherichia coli and lactic acid bacteria, the shuttle vector is obtained by linking the ampicillin resistance gene and promoter and pMB1 replicon sequence into the Lactobacillus acidophilus plasmid pDX, the shuttle vector pDXA base The sequence is shown in SEQ ID NO:1; the sequence of the plasmid pDX is shown in SEQ ID NO:2.

本发明提供了穿梭载体的应用,本发明的穿梭载体pDXA可在大肠杆菌中表达植酸酶、蛋白酶、淀粉酶和纤维素酶的基因。The invention provides the application of the shuttle vector, and the shuttle vector pDXA of the invention can express the genes of phytase, protease, amylase and cellulase in Escherichia coli.

与现有技术相比,本发明的穿梭载体pDXA可在大肠杆菌、乳脂乳球菌、乳酸乳球菌乳酸亚种、嗜酸乳杆菌、植物乳杆菌、鼠李糖乳杆菌和副干酪乳杆菌中复制及表达外源基因,解决现有质粒载体宿主范围窄的问题。本发明的穿梭载体不仅可以在大肠杆菌和不同乳酸菌内穿梭,还可以在乳脂乳球菌、乳酸乳球菌乳酸亚种、嗜酸乳杆菌、植物乳杆菌、鼠李糖乳杆菌和副干酪乳杆菌中复制遗传至60代。利用本发明穿梭载体在大肠杆菌中表达酶基因,其酶基因的表达水平比利用大肠杆菌磷酸葡萄糖异构酶基因启动子高347%以上。利用该质粒载体在大肠杆菌宿主中完成目的基因克隆和载体构建工作,便于在乳酸菌中开展功能基因表达研究和乳酸菌遗传改造工作。Compared with the prior art, the shuttle vector pDXA of the present invention can replicate in Escherichia coli, Lactococcus lactis, Lactococcus lactis subspecies, Lactobacillus acidophilus, Lactobacillus plantarum, Lactobacillus rhamnosus and Lactobacillus paracasei And express foreign genes, solve the problem of narrow host range of existing plasmid vectors. The shuttle carrier of the present invention can not only shuttle in Escherichia coli and different lactic acid bacteria, but also in Lactococcus lactis, Lactococcus lactis subsp. lactis, Lactobacillus acidophilus, Lactobacillus plantarum, Lactobacillus rhamnosus and Lactobacillus paracasei Replication inherited to 60 generations. The shuttle vector of the present invention is used to express the enzyme gene in Escherichia coli, and the expression level of the enzyme gene is more than 347% higher than that of the Escherichia coli phosphate glucose isomerase gene promoter. The plasmid vector is used to complete the cloning of the target gene and the construction of the vector in the Escherichia coli host, which is convenient for carrying out functional gene expression research and genetic transformation of the lactic acid bacteria in the lactic acid bacteria.

附图说明Description of drawings

图1为琼脂糖凝胶电泳检测质粒;最左边泳道为DNA Marker,最右边泳道为提取的质粒,显示有三条质粒条带,质粒pDX为其中最小的质粒条带。Figure 1 shows the plasmid detected by agarose gel electrophoresis; the leftmost lane is the DNA Marker, and the rightmost lane is the extracted plasmid, showing three plasmid bands, and the plasmid pDX is the smallest plasmid band.

图2为质粒pDX图谱;图谱中dso为质粒复制双链起点,sso为质粒复制单链起点,ORF1 rep编码复制起始蛋白。Figure 2 is the plasmid pDX map; in the map, dso is the double-strand origin of plasmid replication, sso is the single-strand origin of plasmid replication, and ORF1 rep encodes the replication initiation protein.

图3为穿梭载体pDXA图谱;图谱中pMB1为复制起始序列,AmpR为氨苄青霉素抗性基因。Figure 3 is the map of the shuttle vector pDXA; in the map, pMB1 is the replication initiation sequence, and AmpR is the ampicillin resistance gene.

图4为乳酸菌启动子表达酶基因。Fig. 4 shows the enzyme gene expressed by the lactic acid bacteria promoter.

具体实施方式Detailed ways

下面结合具体实施例对本发明一种大肠杆菌与乳酸菌的穿梭载体pDXA及构建方法与应用作进一步的详细说明。A shuttle vector pDXA between Escherichia coli and lactic acid bacteria of the present invention and its construction method and application will be further described in detail below in conjunction with specific examples.

实施例1:质粒pDX的提取Embodiment 1: the extraction of plasmid pDX

在37℃条件下MRS液体培养基中静置培养嗜酸乳杆菌24h,离心收集菌体,用50mg/mL溶菌酶溶液(10mmol/L Tris-HCl、5mmol/L EDTA,pH 8.0),在37℃条件下处理1h,用质粒小量提取试剂盒提取质粒。利用琼脂糖凝胶电泳检测确认质粒大小,所述琼脂糖凝胶电泳结果如图1所示,结果显示质粒提取液有3个条带,说明该菌株携带多个质粒,对其中大小约2kb的小质粒进行纯化回收,此质粒为pDX,并对其进行序列测定。Culture Lactobacillus acidophilus statically in MRS liquid medium at 37°C for 24 hours, collect the bacteria by centrifugation, and use 50mg/mL lysozyme solution (10mmol/L Tris-HCl, 5mmol/L EDTA, pH 8.0) at 37 Treat at ℃ for 1 h, and extract the plasmid with a plasmid mini-extraction kit. Utilize agarose gel electrophoresis to detect and confirm the size of the plasmid, and the agarose gel electrophoresis result is as shown in Figure 1, and the result shows that there are 3 bands in the plasmid extract, indicating that the bacterial strain carries multiple plasmids, and about 2kb of them in size The small plasmid was purified and recovered, and the plasmid was pDX, and its sequence was determined.

实施例2:穿梭载体的构建Embodiment 2: the construction of shuttle carrier

通过基因合成氨苄青霉素抗性基因及启动子和pMB1复制子序列,并连接到嗜酸乳杆菌质粒pDX中,构建获得穿梭载体pDXA,所述质粒pDX如图2所示,所述质粒pDXA如图3所示。合成与质粒pDX中的ORF3的启动子相接的四环素抗性基因,并连接到载体pDXA中,构建获得载体pDXAO3。合成大肠杆菌磷酸葡萄糖异构酶基因启动子及四环素抗性基因,并连接到载体pDXA中,构建获得载体pDXAPGI。By genetically synthesizing the ampicillin resistance gene, promoter and pMB1 replicon sequence, and connecting it to the Lactobacillus acidophilus plasmid pDX, the shuttle vector pDXA is constructed, the plasmid pDX is shown in Figure 2, and the plasmid pDXA is shown in Figure 2 3. A tetracycline resistance gene connected with the promoter of ORF3 in the plasmid pDX was synthesized and connected to the vector pDXA to construct the vector pDXAO3. Synthesize the Escherichia coli phosphoglucose isomerase gene promoter and tetracycline resistance gene, and link them into the vector pDXA to construct the vector pDXAPGI.

实施例3:穿梭载体启动子在大肠杆菌中的活性检测Example 3: Activity detection of the shuttle vector promoter in Escherichia coli

通过基因合成氨苄青霉素抗性基因及启动子和pMB1复制子序列,并连接到嗜酸乳杆菌XW118的质粒pDX中,构建获得穿梭载体pDXA。合成分别与质粒pDX中的ORF1、ORF2、ORF3和ORF4的启动子相接的四环素抗性基因,并连接到载体pDXA中,分别构建获得载体pDXAO1、pDXAO2、pDXAO3和pDXAO4。所述质粒载体pDXAO1序列如SEQ ID NO:3所示;所述质粒载体pDXAO2序列如SEQ ID NO:4所示;所述质粒载体pDXAO3序列如SEQ ID NO:5所示;所述质粒载体pDXAO4序列如SEQ ID NO:6所示。合成大肠杆菌磷酸葡萄糖异构酶基因启动子及四环素抗性基因,并连接到载体pDXA中,构建获得载体pDXAPGI。将穿梭载体pDXAO1、pDXAO2、pDXAO3、pDXAO4及pDXAPGI分别转化大肠杆菌ATCC25922中,涂布含氨苄青霉素的LB平板培养分别获得相应转化子。将大肠杆菌转化子涂布于含50μg/mL四环素的LB平板,在37℃条件下进行培养,观察培养后是否有转化子菌落长出。结果显示大肠杆菌DXAO3、大肠杆菌DXAO4和大肠杆菌DXAPGI有菌落长出,大肠杆菌DXAO1和大肠杆菌DXAO2没有菌落长出。嗜酸乳杆菌内源性质粒ORF3和ORF4的启动子在大肠杆菌中具有活性,能作为大肠杆菌启动子元件用于基因表达。The shuttle vector pDXA was constructed by synthesizing the ampicillin resistance gene, promoter and pMB1 replicon sequence, and connecting them into the plasmid pDX of Lactobacillus acidophilus XW118. Tetracycline resistance genes connected to the promoters of ORF1, ORF2, ORF3 and ORF4 in the plasmid pDX were synthesized and connected to the vector pDXA to construct the vectors pDXAO1, pDXAO2, pDXAO3 and pDXAO4 respectively. The sequence of the plasmid vector pDXAO1 is shown in SEQ ID NO: 3; the sequence of the plasmid vector pDXAO2 is shown in SEQ ID NO: 4; the sequence of the plasmid vector pDXAO3 is shown in SEQ ID NO: 5; the sequence of the plasmid vector pDXAO4 The sequence is shown in SEQ ID NO:6. Synthesize the Escherichia coli phosphoglucose isomerase gene promoter and tetracycline resistance gene, and link them into the vector pDXA to construct the vector pDXAPGI. The shuttle vectors pDXAO1, pDXAO2, pDXAO3, pDXAO4 and pDXAPGI were respectively transformed into Escherichia coli ATCC25922, and cultured on LB plates containing ampicillin to obtain corresponding transformants. Spread Escherichia coli transformants on LB plates containing 50 μg/mL tetracycline, and culture them at 37°C, and observe whether there are colonies of transformants growing after cultivation. The results showed that colonies of Escherichia coli DXAO3, Escherichia coli DXAO4 and Escherichia coli DXAPGI grew, but no colonies of Escherichia coli DXAO1 and Escherichia coli DXAO2 grew. The promoters of the endogenous plasmids ORF3 and ORF4 of Lactobacillus acidophilus are active in Escherichia coli and can be used as Escherichia coli promoter elements for gene expression.

实施例4:穿梭载体的宿主范围Example 4: Host range of shuttle vectors

为了确定大肠杆菌复制子Ori和四环素抗性基因穿梭质粒pDXAO4的宿主菌株范围,通过电击转化将穿梭质粒pDXAO4分别导入到乳脂乳球菌、乳酸乳球菌乳酸亚种、嗜酸乳杆菌、植物乳杆菌、鼠李糖乳杆菌、副干酪乳杆菌和乳酸片球菌的感受态中,乳酸菌转化子涂布于含50μg/mL四环素的MRS平板,在30℃条件下培养,利用抗性标记筛选。结果显示,穿梭质粒均可在乳脂乳球菌、乳酸乳球菌乳酸亚种、嗜酸乳杆菌、植物乳杆菌、鼠李糖乳杆菌、副干酪乳杆菌中实现电转,并得到对应的转化子,但在乳酸片球菌中未获得转化子。In order to determine the host strain range of the Escherichia coli replicon Ori and the tetracycline resistance gene shuttle plasmid pDXAO4, the shuttle plasmid pDXAO4 was introduced into Lactococcus lactis, Lactococcus lactis subsp. lactis, Lactobacillus acidophilus, Lactobacillus plantarum, In the competence of Lactobacillus rhamnosus, Lactobacillus paracasei and Pediococcus lactis, lactic acid bacteria transformants were spread on MRS plates containing 50 μg/mL tetracycline, cultured at 30°C, and screened by resistance markers. The results showed that the shuttle plasmids could be electroporated in Lactococcus lactis, Lactococcus lactis subsp. lactis, Lactobacillus acidophilus, Lactobacillus plantarum, Lactobacillus rhamnosus, and Lactobacillus paracasei, and obtained corresponding transformants, but No transformants were obtained in Pediococcus lactis.

分别取50、200和500ng的穿梭载体pDXAO4与各种乳酸菌感受态混匀,电击转化后于30℃活化3h,涂布于含50μg/mL四环素的MRS平板,在30℃条件下培养至菌落长出。对转化子菌落计数并计算转化效率(取三个梯度中的最高者为最终的转化效率)。挑取含四环素MRS平板上的单菌落接种至含四环素的MRS液体培养基中,37℃培养24h。再以1%接种量接种至MRS液体培养基中,37℃培养12h,并继续按此条件传代培养至60代,菌液分别稀释涂布于含四环素的MRS固体平板和不含四环素的MRS固体平板,根据两种平板上的菌落数计算质粒的丢失率。计算穿梭质粒pDXAO4在各种乳酸菌宿主中的转化效率及质粒稳定性。结果显示穿梭质粒pDXAO4电转化效率在0.24×102至2.75×103CFU/μg(质粒量)之间。穿梭质粒pDXAO4的丢失率在25.45%至48.36%之间,其中穿梭质粒在植物乳杆菌中丢失率为48.36%,在乳脂乳球菌中丢失率为25.45%。所述穿梭载体的宿主范围和转化效率如表1所示。Take 50, 200, and 500 ng of the shuttle vector pDXAO4 and mix them with various lactic acid bacteria in a competent state, activate them at 30°C for 3 hours after electric shock transformation, spread them on MRS plates containing 50 μg/mL tetracycline, and culture them at 30°C until the colonies grow long. out. Count the colonies of transformants and calculate the transformation efficiency (take the highest among the three gradients as the final transformation efficiency). Pick a single colony on the tetracycline-containing MRS plate and inoculate it into the tetracycline-containing MRS liquid medium, and incubate at 37°C for 24h. Then inoculate 1% inoculum into MRS liquid medium, culture at 37°C for 12 hours, and continue to subculture under this condition to 60 generations. The bacterial solution is diluted and spread on MRS solid plate containing tetracycline and MRS solid plate without tetracycline. plate, and calculate the loss rate of the plasmid according to the number of colonies on the two plates. Calculate the transformation efficiency and plasmid stability of the shuttle plasmid pDXAO4 in various lactic acid bacteria hosts. The results showed that the electrotransformation efficiency of the shuttle plasmid pDXAO4 was between 0.24×10 2 and 2.75×10 3 CFU/μg (plasmid amount). The loss rate of the shuttle plasmid pDXAO4 was between 25.45% and 48.36%, among which the loss rate of the shuttle plasmid was 48.36% in Lactobacillus plantarum and 25.45% in Lactococcus lactis. The host range and transformation efficiency of the shuttle vector are shown in Table 1.

表1穿梭质粒pDXAO4在不同宿主中的转化效率和稳定性Table 1 Transformation efficiency and stability of the shuttle plasmid pDXAO4 in different hosts

Figure BDA0003810516430000051
Figure BDA0003810516430000051

实施例5:碳源对启动子的诱导作用Example 5: Induction of promoter by carbon source

分别将葡萄糖、半乳糖、鼠李糖、木糖、果糖和甘露糖作为碳源,在含50μg/mL四环素的培养基上培养含pDXAO2的大肠杆菌转化子。结果显示以葡萄糖、鼠李糖、木糖、果糖和甘露糖作为碳源分别培养时,大肠杆菌DXAO2没有菌落长出。以半乳糖作为碳源培养时,大肠杆菌DXAO2有菌落长出。Glucose, galactose, rhamnose, xylose, fructose and mannose were respectively used as carbon sources, and E. coli transformants containing pDXAO2 were cultured on medium containing 50 μg/mL tetracycline. The results showed that when glucose, rhamnose, xylose, fructose and mannose were cultured separately as carbon sources, no colonies of Escherichia coli DXAO2 grew. Escherichia coli DXAO2 colonies grew when galactose was used as carbon source.

实施例6:乳酸菌启动子用于大肠杆菌表达酶基因Embodiment 6: lactic acid bacteria promoter is used for Escherichia coli expression enzyme gene

分别合成与质粒pDX中的ORF4的启动子相接的植酸酶、淀粉酶、蛋白酶和甘露聚糖酶基因,并连接到载体pDXA中,分别构建获得载体pDXA4P、pDXA4A、pDXA4R和pDXA4C。分别合成大肠杆菌磷酸葡萄糖异构酶基因启动子及植酸酶、淀粉酶、蛋白酶和甘露聚糖酶基因,并分别连接到载体pDXA中,构建获得载体pDXAPP、pDXAPA、pDXAPR和pDXAPC。将穿梭载体pDXA4P、pDXA4A、pDXA4R、pDXA4C、pDXAPP、pDXAPA、pDXAPR和pDXAPC分别转化大肠杆菌ATCC25922中,涂布含氨苄青霉素的LB平板培养分别获得相应转化子。将含pDXA4P、pDXA4A、pDXA4R、pDXA4C、pDXAPP、pDXAPA、pDXAPR和pDXAPC的大肠杆菌转化子发酵培养24h,收集菌体沉淀,分别测定植酸酶、淀粉酶、蛋白酶和甘露聚糖酶的酶活力。结果显示大肠杆菌pDXA4P植酸酶活力为504U/mg,大肠杆菌pDXA4A淀粉酶活力为165U/mg,大肠杆菌pDXA4R蛋白酶活力为387U/mg,大肠杆菌pDXA4C甘露聚糖酶活力为243U/mg,大肠杆菌pDXAPP植酸酶活力为114U/mg,大肠杆菌pDXAPA淀粉酶活力为36U/mg,大肠杆菌pDXAPR蛋白酶活力为52U/mg,大肠杆菌pDXAPC甘露聚糖酶活力为27U/mg,所述植酸酶、淀粉酶、蛋白酶和甘露聚糖酶的酶活力如图4所示。表明ORF4的启动子的强度在酶基因表达方面大于大肠杆菌磷酸葡萄糖异构酶基因启动子。The phytase, amylase, protease and mannanase genes connected to the promoter of ORF4 in the plasmid pDX were respectively synthesized and connected to the vector pDXA to construct the vectors pDXA4P, pDXA4A, pDXA4R and pDXA4C respectively. The Escherichia coli phosphoglucose isomerase gene promoter and phytase, amylase, protease and mannanase genes were synthesized respectively, and respectively connected to the vector pDXA to construct the vectors pDXAPP, pDXAPA, pDXAPR and pDXAPC. The shuttle vectors pDXA4P, pDXA4A, pDXA4R, pDXA4C, pDXAPP, pDXAPA, pDXAPR and pDXAPC were transformed into Escherichia coli ATCC25922, respectively, and LB plates containing ampicillin were cultured to obtain corresponding transformants. The Escherichia coli transformants containing pDXA4P, pDXA4A, pDXA4R, pDXA4C, pDXAPP, pDXAPA, pDXAPR and pDXAPC were fermented and cultured for 24 hours, and the bacterial precipitates were collected, and the enzyme activities of phytase, amylase, protease and mannanase were measured respectively. The results showed that the E. coli pDXA4P phytase activity was 504U/mg, the E. coli pDXA4A amylase activity was 165U/mg, the E. coli pDXA4R protease activity was 387U/mg, and the E. coli pDXA4C mannanase activity was 243U/mg. pDXAPP phytase activity is 114U/mg, Escherichia coli pDXAPA amylase activity is 36U/mg, Escherichia coli pDXAPR protease activity is 52U/mg, Escherichia coli pDXAPC mannanase activity is 27U/mg, described phytase, The enzymatic activities of amylase, protease and mannanase are shown in Figure 4. It shows that the strength of the promoter of ORF4 is greater than that of E. coli phosphoglucose isomerase gene promoter in terms of enzyme gene expression.

所述植酸酶基因序列如SEQ ID NO:7所示;所述甘露聚糖酶基因序列如SEQ IDNO:8所示;所述蛋白酶基因序列如SEQ ID NO:9所示;所述淀粉酶基因序列如SEQ ID NO:10所示。The phytase gene sequence is shown in SEQ ID NO: 7; the mannanase gene sequence is shown in SEQ ID NO: 8; the protease gene sequence is shown in SEQ ID NO: 9; the amylase The gene sequence is shown in SEQ ID NO:10.

所述植酸酶活性单位:样品在底物植酸钠浓度为5.0mmol/L、温度37℃、PH值5.5的条件下,每小时从植酸钠中释放1μmol无机磷,即为一个植酸酶活性单位,以U表示。The phytase activity unit: the sample releases 1 μmol of inorganic phosphorus per hour from sodium phytate under the conditions of substrate sodium phytate concentration of 5.0 mmol/L, temperature of 37°C, and pH value of 5.5, which is one phytic acid Enzyme activity unit, expressed in U.

所述淀粉酶活性单位:样品在底物可溶性淀粉浓度为10g/L、温度37℃、PH值6.0的条件下,每小时从底物淀粉中催化产生1μmol还原糖所需的酶量为一个活力单位,用U表示。The amylase activity unit: the amount of enzyme required to catalyze the production of 1 μmol reducing sugar from substrate starch per hour under the conditions of substrate soluble starch concentration of 10 g/L, temperature of 37°C, and pH value of 6.0 is one activity The unit is represented by U.

所述蛋白酶活性单位:样品在底物酪蛋白浓度为10g/L、温度37℃、PH值7.0的条件下,每小时从底物酪蛋白中催化产生1μmol酪氨酸,即为一个蛋白酶活性单位,以U表示。The protease activity unit: when the sample is catalyzed to produce 1 μmol of tyrosine per hour from the substrate casein under the conditions of substrate casein concentration of 10 g/L, temperature of 37°C, and pH value of 7.0, it is a protease activity unit , represented by U.

所述甘露聚糖酶活性单位:样品在底物甘露聚糖浓度为3g/L、温度37℃、PH值5.5条件下,每小时由底物产生1μmol还原糖所需的酶量为一个活力单位,用U表示。The mannanase activity unit: the amount of enzyme required to produce 1 μmol of reducing sugar from the substrate per hour under the conditions of substrate mannan concentration of 3 g/L, temperature of 37°C, and pH value of 5.5 is an activity unit , represented by U.

实施例7:乳酸菌启动子用于乳酸菌表达酶基因Embodiment 7: lactic acid bacteria promoter is used for lactic acid bacteria expression enzyme gene

分别合成与质粒pDX中的ORF4的启动子相接的植酸酶、淀粉酶、蛋白酶和甘露聚糖酶基因,并连接到载体pDXAO3中,分别构建获得载体pDXA34P、pDXA34A、pDXA34R和pDXA34C;分别将载体pDXA34P、pDXA34A、pDXA34R和pDXA34C转化嗜酸乳杆菌中,涂布含四环素的平板培养分别获得相应转化子。将含pDXA34P、pDXA34A、pDXA34R和pDXA34C的嗜酸乳杆菌转化子发酵培养48h,收集嗜酸乳杆菌菌体沉淀,分别测定植酸酶、淀粉酶、蛋白酶和甘露聚糖酶的酶活力。结果显示嗜酸乳杆菌pDXA4P植酸酶活力为857U/mg,嗜酸乳杆菌pDXA4A淀粉酶活力为1205U/mg,嗜酸乳杆菌pDXA4R蛋白酶活力为792U/mg,嗜酸乳杆菌pDXA4C甘露聚糖酶活力为517U/mg,所述植酸酶、淀粉酶、蛋白酶和甘露聚糖酶的酶活力如表2所示。The phytase, amylase, protease and mannanase genes connected to the promoter of ORF4 in the plasmid pDX were synthesized respectively, and connected to the vector pDXAO3 to construct the vectors pDXA34P, pDXA34A, pDXA34R and pDXA34C respectively; The vectors pDXA34P, pDXA34A, pDXA34R and pDXA34C were transformed into Lactobacillus acidophilus, and the corresponding transformants were respectively obtained by coating the plates containing tetracycline. The transformants of Lactobacillus acidophilus containing pDXA34P, pDXA34A, pDXA34R and pDXA34C were fermented and cultured for 48 hours, the precipitates of Lactobacillus acidophilus were collected, and the enzyme activities of phytase, amylase, protease and mannanase were measured respectively. The results showed that the phytase activity of Lactobacillus acidophilus pDXA4P was 857U/mg, the activity of Lactobacillus acidophilus pDXA4A amylase was 1205U/mg, the activity of protease activity of Lactobacillus acidophilus pDXA4R was 792U/mg, and the activity of Lactobacillus acidophilus pDXA4C mannanase The activity is 517U/mg, and the enzyme activities of the phytase, amylase, protease and mannanase are shown in Table 2.

表2重组嗜酸乳杆菌产酶Table 2 Recombinant Lactobacillus acidophilus produces enzyme

Figure BDA0003810516430000071
Figure BDA0003810516430000071

分别将载体pDXA34P转化到乳脂乳球菌、乳酸乳球菌乳酸亚种、嗜酸乳杆菌、植物乳杆菌、鼠李糖乳杆菌、副干酪乳杆菌中,涂布含四环素的平板培养分别获得相应转化子。将含pDXA34P的乳酸菌转化子发酵培养48h,分别测定植酸酶的酶活力,结果表明不同的乳酸菌转化子都能产植酸酶,所述乳脂乳球菌、乳酸乳球菌乳酸亚种、嗜酸乳杆菌、植物乳杆菌、鼠李糖乳杆菌、副干酪乳杆菌的转化子产植酸酶的酶活力如表3所示。Transform the vector pDXA34P into Lactococcus cremoris, Lactococcus lactis subsp. lactis, Lactobacillus acidophilus, Lactobacillus plantarum, Lactobacillus rhamnosus, Lactobacillus paracasei, respectively, and culture on plates containing tetracycline to obtain corresponding transformants . The lactic acid bacteria transformants containing pDXA34P were fermented and cultivated for 48h, and the enzyme activity of phytase was measured respectively. The results showed that different lactic acid bacteria transformants could produce phytase, and the Lactococcus lactis, Lactococcus lactis subsp. The enzyme activity of phytase produced by transformants of Bacillus, Lactobacillus plantarum, Lactobacillus rhamnosus, and Lactobacillus paracasei is shown in Table 3.

所述植酸酶基因序列如SEQ ID NO:7所示;所述纤维素酶基因序列如SEQ ID NO:8所示;所述蛋白酶基因序列如SEQ ID NO:9所示;所述淀粉酶基因序列如SEQ ID NO:10所示。The phytase gene sequence is shown in SEQ ID NO: 7; the cellulase gene sequence is shown in SEQ ID NO: 8; the protease gene sequence is shown in SEQ ID NO: 9; the amylase The gene sequence is shown in SEQ ID NO:10.

所述植酸酶活性单位:样品在底物植酸钠浓度为5.0mmol/L、温度37℃、PH值5.5的条件下,每小时从植酸钠中释放1μmol无机磷,即为一个植酸酶活性单位,以U表示。The phytase activity unit: the sample releases 1 μmol of inorganic phosphorus per hour from sodium phytate under the conditions of substrate sodium phytate concentration of 5.0 mmol/L, temperature of 37°C, and pH value of 5.5, which is one phytic acid Enzyme activity unit, expressed in U.

所述淀粉酶活性单位:样品在底物可溶性淀粉浓度为10g/L、温度37℃、PH值6.0的条件下,每小时从底物淀粉中催化产生1μmol还原糖所需的酶量为一个活力单位,用U表示。The amylase activity unit: the amount of enzyme required to catalyze the production of 1 μmol reducing sugar from substrate starch per hour under the conditions of substrate soluble starch concentration of 10 g/L, temperature of 37°C, and pH value of 6.0 is one activity The unit is represented by U.

所述蛋白酶活性单位:样品在底物酪蛋白浓度为10g/L、温度37℃、PH值7.0的条件下,每小时从底物酪蛋白中催化产生1μmol酪氨酸,即为一个蛋白酶活性单位,以U表示。The protease activity unit: when the sample is catalyzed to produce 1 μmol of tyrosine per hour from the substrate casein under the conditions of substrate casein concentration of 10 g/L, temperature of 37°C, and pH value of 7.0, it is a protease activity unit , represented by U.

所述甘露聚糖酶活性单位:样品在底物甘露聚糖浓度为3g/L、温度37℃、PH值5.5条件下,每小时由底物产生1μmol还原糖所需的酶量为一个活力单位,用U表示。The mannanase activity unit: the amount of enzyme required to produce 1 μmol of reducing sugar from the substrate per hour under the conditions of substrate mannan concentration of 3 g/L, temperature of 37°C, and pH value of 5.5 is an activity unit , represented by U.

表3重组乳酸菌产植酸酶Table 3 Phytase produced by recombinant lactic acid bacteria

Figure BDA0003810516430000081
Figure BDA0003810516430000081

以上所述仅为本发明的较佳实施例而已,并不用以限制本发明,任何熟悉本技术领域的技术人员在本发明揭露的技术范围内,可轻易想到的变化或替换,都应涵盖在本发明的保护范围的内。因此,本发明的保护范围应该以权利要求所界定的保护范围为准。The above descriptions are only preferred embodiments of the present invention, and are not intended to limit the present invention. Any changes or substitutions that can be easily conceived by those skilled in the art within the technical scope disclosed in the present invention should be included in the present invention. Within the protection scope of the present invention. Therefore, the protection scope of the present invention should be defined by the claims.

Figure IDA0003810516490000011
Figure IDA0003810516490000011

Figure IDA0003810516490000021
Figure IDA0003810516490000021

Figure IDA0003810516490000031
Figure IDA0003810516490000031

Figure IDA0003810516490000041
Figure IDA0003810516490000041

Figure IDA0003810516490000051
Figure IDA0003810516490000051

Figure IDA0003810516490000061
Figure IDA0003810516490000061

Figure IDA0003810516490000071
Figure IDA0003810516490000071

Figure IDA0003810516490000081
Figure IDA0003810516490000081

Figure IDA0003810516490000091
Figure IDA0003810516490000091

Figure IDA0003810516490000101
Figure IDA0003810516490000101

Figure IDA0003810516490000111
Figure IDA0003810516490000111

Figure IDA0003810516490000121
Figure IDA0003810516490000121

Figure IDA0003810516490000131
Figure IDA0003810516490000131

Figure IDA0003810516490000141
Figure IDA0003810516490000141

Figure IDA0003810516490000151
Figure IDA0003810516490000151

Figure IDA0003810516490000161
Figure IDA0003810516490000161

Figure IDA0003810516490000171
Figure IDA0003810516490000171

Figure IDA0003810516490000181
Figure IDA0003810516490000181

Figure IDA0003810516490000191
Figure IDA0003810516490000191

Figure IDA0003810516490000201
Figure IDA0003810516490000201

Figure IDA0003810516490000211
Figure IDA0003810516490000211

Figure IDA0003810516490000221
Figure IDA0003810516490000221

Figure IDA0003810516490000231
Figure IDA0003810516490000231

Figure IDA0003810516490000241
Figure IDA0003810516490000241

Figure IDA0003810516490000251
Figure IDA0003810516490000251

Figure IDA0003810516490000261
Figure IDA0003810516490000261

Claims (3)

1. A shuttle vector pDXA of escherichia coli and lactobacillus, which is characterized in that the nucleotide sequence is shown in SEQ ID NO: 1.
2. The method of constructing a shuttle vector pDXA according to claim 1, comprising the steps of: the shuttle vector pDXA is constructed and obtained by synthesizing ampicillin resistance gene, promoter and pMB1 replicon sequence through genes and connecting the genes to lactobacillus acidophilus plasmid pDX; the plasmid pDX has a sequence shown in SEQ ID NO:2 is shown in the figure; the ampicillin resistance gene, the promoter and the pMB1 replicon sequence are shown in SEQ ID NO: 3.
3. Use of the shuttle vector pDXA according to claim 1 for the preparation of a pharmaceutical, food and feed additive.
CN202211010845.XA 2022-08-23 2022-08-23 A shuttle vector pDXA between Escherichia coli and lactic acid bacteria and its construction method and application Pending CN116144690A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202211010845.XA CN116144690A (en) 2022-08-23 2022-08-23 A shuttle vector pDXA between Escherichia coli and lactic acid bacteria and its construction method and application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202211010845.XA CN116144690A (en) 2022-08-23 2022-08-23 A shuttle vector pDXA between Escherichia coli and lactic acid bacteria and its construction method and application

Publications (1)

Publication Number Publication Date
CN116144690A true CN116144690A (en) 2023-05-23

Family

ID=86339502

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202211010845.XA Pending CN116144690A (en) 2022-08-23 2022-08-23 A shuttle vector pDXA between Escherichia coli and lactic acid bacteria and its construction method and application

Country Status (1)

Country Link
CN (1) CN116144690A (en)

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5559007A (en) * 1990-03-22 1996-09-24 Suri; Bruno Bacterial shuttle vectors
CN1482247A (en) * 2003-01-13 2004-03-17 王春凤 Non-antibiotics resistant shuttle plasmid expression carrier and its constructing method and uses
KR20040087056A (en) * 2003-04-04 2004-10-13 주식회사 비피도 Foreign gene expression and secretion system in the genus bifidobacterium
KR20060082206A (en) * 2005-01-11 2006-07-18 고려대학교 산학협력단 Transformation Methods and Foreign Protein Expression Vectors for Lactobacillus Species
CN101033471A (en) * 2007-02-08 2007-09-12 四川大学 Colibacillus-lactic acid bacteria shuttle plasmid capable of expressing and excreting beta-galactosidase and its construction method and application
CN101220370A (en) * 2008-01-22 2008-07-16 重庆医科大学 Bifidobacterium-Escherichia coli shuttle expression vector and its preparation method and application
CN111601895A (en) * 2017-12-29 2020-08-28 玫帝托克斯股份有限公司 Promoter polynucleotides, signal polypeptides and uses thereof

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5559007A (en) * 1990-03-22 1996-09-24 Suri; Bruno Bacterial shuttle vectors
CN1482247A (en) * 2003-01-13 2004-03-17 王春凤 Non-antibiotics resistant shuttle plasmid expression carrier and its constructing method and uses
KR20040087056A (en) * 2003-04-04 2004-10-13 주식회사 비피도 Foreign gene expression and secretion system in the genus bifidobacterium
KR20060082206A (en) * 2005-01-11 2006-07-18 고려대학교 산학협력단 Transformation Methods and Foreign Protein Expression Vectors for Lactobacillus Species
CN101033471A (en) * 2007-02-08 2007-09-12 四川大学 Colibacillus-lactic acid bacteria shuttle plasmid capable of expressing and excreting beta-galactosidase and its construction method and application
CN101220370A (en) * 2008-01-22 2008-07-16 重庆医科大学 Bifidobacterium-Escherichia coli shuttle expression vector and its preparation method and application
CN111601895A (en) * 2017-12-29 2020-08-28 玫帝托克斯股份有限公司 Promoter polynucleotides, signal polypeptides and uses thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CHEN, H.等: "Lactiplantibacillus plantarum strain TK-P2A plasmid p.P2A.2, complete sequence", GENBANK DATABASE, 12 November 2020 (2020-11-12), pages 045595 *
方来杉: "植物乳杆菌内源性质粒序列分析及其表达载体的构建", 中国优秀硕士学位论文全文数据库农业科技辑, 15 February 2022 (2022-02-15), pages 11 *
方来杉;赖强;钟泽民;黄毓茂;: "植物乳杆菌内源性质粒序列分析及其表达载体的构建", 食品科学, no. 04, 4 March 2019 (2019-03-04), pages 118 - 124 *

Similar Documents

Publication Publication Date Title
CN112574977B (en) Enzyme special for galactooligosaccharide production and preparation and application thereof
WO2021063355A1 (en) Method for constructing food-grade ethanol-degrading bacillus subtilis recombinant bacteria
CN110157654A (en) A kind of Bacillus natto recombinant bacteria and its construction method and application
CN112522173A (en) Engineering bacterium for producing heterologous alkaline protease and construction method thereof
CN105861536A (en) Preparation method and application of self-induction enhanced engineering bacterium for synthesizing trehalose synthase
Li et al. Food-grade expression of nattokinase in Lactobacillus delbrueckii subsp. bulgaricus and its thrombolytic activity in vitro
CN110846268A (en) A food-grade Lactobacillus plantarum expression system and its application in the preparation of yogurt
CN108220219B (en) A set of Lactobacillus plantarum food-grade expression system and its application in heterologous protein expression
US8426190B2 (en) Stress tolerant Bifidobacteria
WO2023216885A1 (en) Polypeptide having glycoside hydrolase activity, preparation method therefor, and use thereof
CN113151270A (en) Promoter for efficiently expressing alkaline protease and application thereof
CN109234299B (en) A kind of method for expressing and preparing lactobiose phosphorylase
CN109295087B (en) A method for expressing and preparing UDP-glucose-hexose-1-phosphate uridyltransferase
CN105039374A (en) Starch induction type recombinant bacillus subtilis as well as preparation method and application thereof
KR101613897B1 (en) Shuttle vector comprising a promoter inducibly expressed under bile acid and composition comprising the same
CN109652436B (en) Recombinant lactococcus lactis strain and preparation method and application thereof
CN107254428A (en) A kind of Expression Systems for Lactic Acid Bacteria for expressing antifreeze peptide builds and its applied
CN104774863B (en) A kind of method for improving Lactococcus lactis Microcystin stress resistance
CN116144690A (en) A shuttle vector pDXA between Escherichia coli and lactic acid bacteria and its construction method and application
JP3746556B2 (en) Plasmids and plasmid vectors
CN109957538A (en) A kind of genetic engineering bacteria for preparing sarcosine oxidase and its preparation method and application
CN105349565A (en) Rapid screening system for Lactococcus lactis with knocked-in exogenous genes as well as construction method and application of rapid screening system
CN113881618B (en) Recombinant bacillus subtilis secreting milk casein, and construction method and application thereof
CN110878293B (en) Application of bacillus licheniformis with deletion of yceD gene in production of heterologous protein
CN114480211A (en) Wild enterococcus faecium ZK03, and electric shock transformation method and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination